A citation-based method for searching scientific literature

Hanno M Witte, Axel Künstner, Nadine Hertel, Heinz-Wolfram Bernd, Veronica Bernard, Stephanie Stölting, Hartmut Merz, Nikolas von Bubnoff, Hauke Busch, Alfred C Feller, Niklas Gebauer. Blood Adv 2022
Times Cited: 3







List of co-cited articles
5 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma.
Joan Enric Ramis-Zaldivar, Blanca Gonzalez-Farre, Alina Nicolae, Svetlana Pack, Guillem Clot, Ferran Nadeu, Anja Mottok, Heike Horn, Joo Y Song, Kai Fu,[...]. Haematologica 2021
18
100

HIV-negative plasmablastic lymphoma: not in the mouth.
Jorge J Castillo, Eric S Winer, Dariusz Stachurski, Kimberly Perez, Melhem Jabbour, Cannon Milani, Gerald A Colvin, James N Butera. Clin Lymphoma Myeloma Leuk 2011
67
66

The biology and treatment of plasmablastic lymphoma.
Jorge J Castillo, Michele Bibas, Roberto N Miranda. Blood 2015
247
66

Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases.
Julie Morscio, Daan Dierickx, Jan Nijs, Gregor Verhoef, Emilie Bittoun, Xanne Vanoeteren, Iwona Wlodarska, Xavier Sagaert, Thomas Tousseyn. Am J Surg Pathol 2014
145
66

Plasmablastic lymphoma: current perspectives.
Andres Lopez, Pau Abrisqueta. Blood Lymphat Cancer 2018
48
66

Epstein-Barr virus-associated lymphomas.
Claire Shannon-Lowe, Alan B Rickinson, Andrew I Bell. Philos Trans R Soc Lond B Biol Sci 2017
198
33

Plasmablastic lymphoma: a systematic review.
Jorge J Castillo, John L Reagan. ScientificWorldJournal 2011
93
33

Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma.
Jorge J Castillo, Eric S Winer, Dariusz Stachurski, Kimberly Perez, Melhem Jabbour, Cannon Milani, Gerald Colvin, James N Butera. Leuk Lymphoma 2010
124
33

The CXCR4-STAT3-IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by Lenalidomide.
Hila Shaim, Zeev Estrov, David Harris, Mayra Hernandez Sanabria, Zhiming Liu, Peter Ruvolo, Phillip A Thompson, Alessandra Ferrajoli, May Daher, Jan Burger,[...]. Front Immunol 2018
20
33

Plasmablastic lymphoma in immunocompetent and in immunocompromised patients: Experience at a regional cancer centre in India.
A H Rudresha, K C Lakshmaiah, Ankit Agarwal, K Govind Babu, D Loknatha, Linu Abraham Jacob, Suresh Babu, K N Lokesh, L K Rajeev. South Asian J Cancer 2017
9
33

Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma.
Fabian Frontzek, Annette M Staiger, Myroslav Zapukhlyak, Wendan Xu, Irina Bonzheim, Vanessa Borgmann, Philip Sander, Maria Joao Baptista, Jan-Niklas Heming, Philipp Berning,[...]. Nat Commun 2021
10
33

The Emerging Treatment Options of Plasmablastic Lymphoma: Analysis of 173 Individual Patient Outcomes.
Nafie F Makady, David Ramzy, Ramy Ghaly, Raafat R Abdel-Malek, Kyrillus S Shohdy. Clin Lymphoma Myeloma Leuk 2021
5
33


Advances in Virus-Directed Therapeutics against Epstein-Barr Virus-Associated Malignancies.
Sajal K Ghosh, Susan P Perrine, Douglas V Faller. Adv Virol 2012
39
33


Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy.
Abraham S Kanate, Navneet S Majhail, Bipin N Savani, Christopher Bredeson, Richard E Champlin, Stephen Crawford, Sergio A Giralt, Charles F LeMaistre, David I Marks, James L Omel,[...]. Biol Blood Marrow Transplant 2020
71
33

Epstein-Barr virus positive diffuse large B-cell lymphoma predict poor outcome, regardless of the age.
Ting-Xun Lu, Jin-Hua Liang, Yi Miao, Lei Fan, Li Wang, Xiao-Yan Qu, Lei Cao, Qi-Xing Gong, Zhen Wang, Zhi-Hong Zhang,[...]. Sci Rep 2015
73
33


Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12.
Michael Crump, John Kuruvilla, Stephen Couban, David A MacDonald, Vishal Kukreti, C Tom Kouroukis, Morel Rubinger, Rena Buckstein, Kevin R Imrie, Massimo Federico,[...]. J Clin Oncol 2014
256
33


Cancer immunotherapy: a treatment for the masses.
Joseph N Blattman, Philip D Greenberg. Science 2004
424
33

The tumour microenvironment is immuno-tolerogenic and a principal determinant of patient outcome in EBV-positive diffuse large B-cell lymphoma.
Colm Keane, Joshua Tobin, Jay Gunawardana, Santiyagu Francis, Grace Gifford, Sara Gabrielli, Anthony Gill, William Stevenson, Dipti Talaulikar, Clare Gould,[...]. Eur J Haematol 2019
26
33


A novel Epstein-Barr virus-latent membrane protein-1-specific T-cell receptor for TCR gene therapy.
Hyun-Il Cho, Un-Hee Kim, A-Ri Shin, Ji-Na Won, Hyun-Joo Lee, Hyun-Jung Sohn, Tai-Gyu Kim. Br J Cancer 2018
21
33

Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy.
Zhiyu Liu, Zijun Y Xu-Monette, Xin Cao, Ganiraju C Manyam, Xiaoxiao Wang, Alexandar Tzankov, Yi Xia, Xin Li, Carlo Visco, Ruifang Sun,[...]. Mod Pathol 2015
17
33

Epstein-Barr virus (EBV) DNA in whole blood as a superior prognostic and monitoring factor than EBV-encoded small RNA in situ hybridization in diffuse large B-cell lymphoma.
J-H Liang, T-X Lu, T Tian, L Wang, L Fan, J Xu, R Zhang, Q-X Gong, Z-H Zhang, J-Y Li,[...]. Clin Microbiol Infect 2015
18
33

Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphoma.
Jia Ruan, Peter Martin, Richard R Furman, Shing M Lee, Ken Cheung, Julie M Vose, Ann Lacasce, Julia Morrison, Rebecca Elstrom, Scott Ely,[...]. J Clin Oncol 2011
244
33

Refractory Epstein-Barr Virus (EBV)-Related Post-transplant Lymphoproliferative Disease: Cure by Combined Brentuximab Vedotin and Allogeneic EBV-Specific T-Lymphocytes.
Thomas Mika, Katharina Strate, Swetlana Ladigan, Clemens Aigner, Uwe Schlegel, Iris Tischoff, Sabine Tischer-Zimmermann, Britta Eiz-Vesper, Britta Maecker-Kolhoff, Roland Schroers. Front Med (Lausanne) 2019
13
33

Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma--is it necessary?
Chi Young Ok, Qing Ye, Ling Li, Ganiraju C Manyam, Lijuan Deng, Rashmi R Goswami, Xiaoxiao Wang, Santiago Montes-Moreno, Carlo Visco, Alexandar Tzankov,[...]. Oncotarget 2015
32
33

Epstein-Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update.
Maria K Smatti, Duaa W Al-Sadeq, Nadima H Ali, Gianfranco Pintus, Haissam Abou-Saleh, Gheyath K Nasrallah. Front Oncol 2018
109
33


Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma.
Thomas M Habermann, Edie A Weller, Vicki A Morrison, Randy D Gascoyne, Peter A Cassileth, Jeffrey B Cohn, Shaker R Dakhil, Bruce Woda, Richard I Fisher, Bruce A Peterson,[...]. J Clin Oncol 2006
33

EBV-positive diffuse large B-cell lymphoma of the elderly: a case series from Peru.
Brady E Beltran, Jorge J Castillo, Domingo Morales, Fernando Hurtado de Mendoza, Pilar Quinones, Roberto N Miranda, Aly Gallo, Marco Lopez-Ilasaca, James N Butera, Eduardo M Sotomayor. Am J Hematol 2011
50
33

Epstein-Barr virus-associated B-cell lymphoproliferative disorders and lymphomas: a review.
Mario L Marques-Piubelli, Yessenia I Salas, Carlos Pachas, Renato Becker-Hecker, Francisco Vega, Roberto N Miranda. Pathology 2020
26
33

Deletion of Viral microRNAs in the Oncogenesis of Epstein-Barr Virus-Associated Lymphoma.
Hiroshi Kimura, Yusuke Okuno, Yoshitaka Sato, Takahiro Watanabe, Takayuki Murata. Front Microbiol 2021
7
33

Epigenetic reprogramming sensitizes immunologically silent EBV+ lymphomas to virus-directed immunotherapy.
Tanner Dalton, Ekaterina Doubrovina, Dmitry Pankov, Raymond Reynolds, Hanna Scholze, Annamalai Selvakumar, Teresa Vizconde, Bhumesh Savalia, Vadim Dyomin, Christoph Weigel,[...]. Blood 2020
17
33

CAR-T Cells Targeting Epstein-Barr Virus gp350 Validated in a Humanized Mouse Model of EBV Infection and Lymphoproliferative Disease.
Constanze Slabik, Maja Kalbarczyk, Simon Danisch, Reinhard Zeidler, Frank Klawonn, Valery Volk, Nicole Krönke, Friedrich Feuerhake, Constanca Ferreira de Figueiredo, Rainer Blasczyk,[...]. Mol Ther Oncolytics 2020
18
33

Clinicopathological features and survival in EBV-positive diffuse large B-cell lymphoma not otherwise specified.
Estelle Bourbon, Delphine Maucort-Boulch, Juliette Fontaine, Claire Mauduit, Pierre Sesques, Violaine Safar, Emmanuelle Ferrant, Camille Golfier, Dana Ghergus, Lionel Karlin,[...]. Blood Adv 2021
12
33

Clinical impact of serum survivin positivity and tissue expression of EBV-encoded RNA in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.
Jung Yong Hong, Kyung Ju Ryu, Chaehwa Park, Mineui Hong, Young Hyeh Ko, Won Seog Kim, Seok Jin Kim. Oncotarget 2017
15
33


Cellular Immunotherapy for Refractory Diffuse Large B Cell Lymphoma in the Chimeric Antigen Receptor-Engineered T Cell Era: Still a Role for Allogeneic Transplantation?
Peter Dreger, Timothy S Fenske, Silvia Montoto, Marcelo C Pasquini, Anna Sureda, Mehdi Hamadani. Biol Blood Marrow Transplant 2020
27
33

Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins.
Catherine M Bollard, Stephen Gottschalk, Vicky Torrano, Oumar Diouf, Stephanie Ku, Yasmin Hazrat, George Carrum, Carlos Ramos, Luis Fayad, Elizabeth J Shpall,[...]. J Clin Oncol 2014
334
33

Diffuse large B-cell lymphoma variants: an update.
Narittee Sukswai, Kirill Lyapichev, Joseph D Khoury, L Jeffrey Medeiros. Pathology 2020
62
33


Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era.
Christian Gisselbrecht, Bertram Glass, Nicolas Mounier, Devinder Singh Gill, David C Linch, Marek Trneny, Andre Bosly, Nicolas Ketterer, Ofer Shpilberg, Hans Hagberg,[...]. J Clin Oncol 2010
33

Phenogenomic heterogeneity of post-transplant plasmablastic lymphomas.
Rebecca J Leeman-Neill, Craig R Soderquist, Francesca Montanari, Patricia Raciti, David Park, Dejan Radeski, Mahesh M Mansukhani, Vundavalli V Murty, Susan Hsiao, Bachir Alobeid,[...]. Haematologica 2022
5
33

Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers.
Mark Cobbold, Naeem Khan, Batoul Pourgheysari, Sudhir Tauro, Dorothy McDonald, Husam Osman, Mario Assenmacher, Lucinda Billingham, Colin Steward, Charles Crawley,[...]. J Exp Med 2005
387
33

Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas.
Jakub Svoboda, Steven M Bair, Daniel J Landsburg, Sunita Dwivedy Nasta, Sarah J Nagle, Stefan K Barta, Nadia Khan, Joanne Filicko-O'Hara, Sameh Gaballa, Lauren Strelec,[...]. Haematologica 2021
23
33

Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation.
Timothy S Fenske, Kwang W Ahn, Tara M Graff, Alyssa DiGilio, Qaiser Bashir, Rammurti T Kamble, Ernesto Ayala, Ulrike Bacher, Jonathan E Brammer, Mitchell Cairo,[...]. Br J Haematol 2016
86
33

The Incidence of Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis.
Jisun Hwang, Chong Hyun Suh, Kyung Won Kim, Ho Sung Kim, Philippe Armand, Raymond Y Huang, Jeffrey P Guenette. Cancers (Basel) 2021
9
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.